Chart
Allergy · Sulfa drugs 36y · Female · MRN MV-700009 · IC 900403-10-1304
Clinical Summary
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn05/10/2026
- Clinical note
- Myopia (H52.1) — BCVA OD 6/6, unchanged; IOP 14 mmHg.
- Diagnosis
- H52.1 Myopia (OU)
- Care plan
- Refraction stable: continue the current spectacles. Review in 6 months.
- Follow-up
- Review 6 mo
Test Reports
- Corneal topography OD 43.1 · OS 44.6 D Kmax05/10/2026
Medications
0No medication on record.
Visit
7 Cataract & Refractive- Upcoming3
- Review 6 mo Dr. Ho Whye Onn03/04/2027
- Review Dr. Ho Whye Onn02/10/2027
- Review Dr. Ho Whye Onn01/04/2028
- Past visits
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn05/10/2026
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn03/10/2026
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn20/08/2026
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn05/07/2026
- New Case · Cataract & Refractive Dr. Ho Whye Onn22/05/2026
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn06/04/2026
- Follow Up · Cataract & Refractive Dr. Ho Whye Onn22/02/2026
Diagnoses
1- H52.1 · Myopia (OU) Since 22/02/2026
Procedure
1- Corneal topography05/10/2026
Vital signs
6Temp 37.2 °CPulse 63 bpmBP 120/87 mmHgSpO₂ 96 %RR 22 /minWt 59.7 kg
Allergy
1- Sulfa drugs Drug · Rash · Mild06/04/2026